AZD-8186 is a small-molecule compound that functions as a phosphatidylinositol 3-kinase inhibitor. It is under investigation in a clinical trial for advanced solid tumors with specific genetic mutations.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
[2-chloro-3-(trifluoromethyl)phenyl]-[(4R)-1-(5-fluoropyrimidin-2-yl)-4-methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridin-5-yl]methanone
pharmaceutical raw material
Caspofungin
pharmaceutical raw material
Sofpironium bromide
pharmaceutical raw material
BPC-157 acetate
pharmaceutical raw material
8-[(1R)-1-(3,5-difluoroanilino)ethyl]-N,N-dimethyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide
LMJFJIDLEAWOQJ-CQSZACIVSA-N
C[C@H](C1=CC(=CC2=C1OC(=CC2=O)N3CCOCC3)C(=O)N(C)C)NC4=CC(=CC(=C4)F)F
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.